M11 implant (270-0411-06-01-F1)
Ended Awarded Last action
- Contract number
- W81XWH22F0287
- Awardee
-
Harvard Bioscience Inc. UEI MUGFN52A5NJ1 Part of Harvard Bioscience Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $62,630
Award facts
- Contract value 100% obligated
- $62,630.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 339113 Surgical Appliance and Supplies Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Mounds View, MN 55112, USA
Award details come from SAM.gov/FPDS.
About this award
Harvard Bioscience Inc., operating through its Data Sciences International division, was awarded a $62,630 firm fixed-price call order under a Blanket Purchase Agreement (BPA) with the Defense Health Agency on September 6, 2022. This task order, designated M11 IMPLANT (270-0411-06-01-F1), calls for the delivery of M11 implantable telemetry devices and related biomedical research equipment to support physiological monitoring applications in preclinical research. The award utilizes the Defense Health Agency's $4.8 million single-award BPA established in May 2022, which enables streamlined procurement of specialized biomedical research solutions through the Army Medical Command and other military health system partners. The contract carries no set-aside designation and specifies performance at the contractor's facility in Mounds View, Minnesota, with an ultimate completion date of September 16, 2022.
Harvard Bioscience is a self-certified small disadvantaged business specializing in wireless implantable telemetry transmitters, physiological monitoring systems, and data acquisition software used across defense, military healthcare, and civilian research sectors. The company has established itself as a critical supplier to multiple federal agencies including the National Institutes of Health, Department of Veterans Affairs, Environmental Protection Agency, and Food and Drug Administration. Under the Defense Health Agency BPA alone, Harvard Bioscience has generated over $1.5 million in cumulative task order value since the agreement's inception, demonstrating its strategic importance to military medical research initiatives. The M11 implant represents part of the contractor's comprehensive portfolio of telemetry devices available for procurement through the indefinite delivery vehicle.
Quick answers
Who was awarded contract W81XWH22F0287?
W81XWH22F0287 was awarded to Harvard Bioscience Inc. by Medical Command (Department of the Army) on September 6, 2022.
How much is contract W81XWH22F0287 worth?
The government has obligated $62,630 on W81XWH22F0287.
Is contract W81XWH22F0287 an order under another contract?
Yes. W81XWH22F0287 is a BPA call under W81XWH22A0001, a blanket purchase agreement.
Was contract W81XWH22F0287 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award